0000950170-24-080600.txt : 20240702
0000950170-24-080600.hdr.sgml : 20240702
20240702164427
ACCESSION NUMBER: 0000950170-24-080600
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240628
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Balcom Alexandra
CENTRAL INDEX KEY: 0001862147
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40671
FILM NUMBER: 241096345
MAIL ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvalent, Inc.
CENTRAL INDEX KEY: 0001861560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 508-446-2272
MAIL ADDRESS:
STREET 1: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
ownership.xml
4
X0508
4
2024-06-28
0001861560
Nuvalent, Inc.
NUVL
0001862147
Balcom Alexandra
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR
CAMBRIDGE
MA
02142
false
true
false
false
Chief Financial Officer
true
Class A Common Stock
2024-06-28
4
M
false
10000
27.85
A
43300
D
Class A Common Stock
2024-06-28
4
S
false
7565
75.15
D
35735
D
Class A Common Stock
2024-06-28
4
S
false
1863
76.19
D
33872
D
Class A Common Stock
2024-06-28
4
S
false
572
76.73
D
33300
D
Stock Option (Right to Buy)
27.85
2024-06-28
4
M
false
10000
0
D
2033-01-06
Class A Common Stock
10000
134200
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.56 to $75.54, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.56 to $76.55, inclusive.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.56 to $77.18, inclusive.
The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
/s/ Nathan McConarty, attorney-in-fact
2024-07-02